Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation

James R. Brasic, J. Y. Barnett, D. Kaplan, B. B. Sheitman, P. Aisemberg, R. T. Lafargue, S. Kowalik, A. Clark, M. O. Tsaltas, J. G. Young

Research output: Contribution to journalArticle

Abstract

In an open, nonblind clinical trial, clomipramine reduced adventitious movementsand compulsions in five previously medicated prepubertal boys with autistic disorder andsevere mental retardation. Poorly adapted rating scales, interrater variability, subjectheterogeneity, different treatment histories, and environmental stresses confounded the assessment of treatment effects.

Original languageEnglish (US)
Pages (from-to)1309-1312
Number of pages4
JournalNeurology
Volume44
Issue number7
StatePublished - Jul 1994
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation'. Together they form a unique fingerprint.

  • Cite this

    Brasic, J. R., Barnett, J. Y., Kaplan, D., Sheitman, B. B., Aisemberg, P., Lafargue, R. T., Kowalik, S., Clark, A., Tsaltas, M. O., & Young, J. G. (1994). Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. Neurology, 44(7), 1309-1312.